GMTA published the following paper: GMTA Welcomes World Health Assembly Resolution on the Importance of Diagnostic Products for Global Public Health [PDF]
GMTA published the following paper: The Need for Advancing Global Convergence of Medical Technology Regulation [PDF]
GMTA published the following paper: White Paper on Data Protection, Privacy and Global Health Data within the Medical Technology Industry [PDF]
GMTA published the following paper: Considerations for Privacy Laws Involving Health Data [PDF]
GMTA published the following paper: Joint statement on global harmonization of ethical business principles in medical technology [PDF]
Japanese version: 医療技術における倫理的事業規範の世界調和に関する共同声明 [PDF]
GMTA published the following paper: Differences between medical devices and drugs [PDF]
GMTA published the following paper: Proposal for a COVID-19 Thought Partnership Forum [PDF]
GMTA published the following paper: Joint Principles on Medical Device Representative Re-entry into Health Care Facilities during the COVID-19 Pandemic [PDF]
GMTA published the following paper: Joint statement on Global Harmonization of Ethical Business Principles in Medical Technology [PDF]
GMTA published the following paper: Medical Device Cybersecurity Principles [PDF]
GMTA published the following paper: Unique Device Identification (UDI): [PDF]
GMTA published the following paper: Principles Regarding The Use of Real World Evidence [PDF]
GMTA published the following paper: AdvaMed Registry Principles [PDF]
GMTA published the following paper: Differences between medical devices and drugs [PDF]
GMTA published the following paper: Patents for Medical Devices and Pharmaceuticals [PDF]
November 2012 GMTA has published a new Position Paper on HTA. Read the full GMTA Position Paper on HTA [PDF]
The Global Medical Technology Alliance (GMTA) represents medical technology associations whose members supply nearly 85 percent of the medical devices and diagnostics purchased annually around the world. These members produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments… Continue reading »
The Global Medical Technology Alliance (GMTA) member associations represent companies that produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. Our represented companies produce nearly 85 percent of the health care technology purchased and utilized annually around the… Continue reading »
December 6, 2010 Dr. Margaret Chan Director General World Health Organization Avenue Appia 20 1211 Geneva 27 Switzerland Dear Director General Chan On behalf of the Global Medical Technology Alliance (GMTA), we are writing to provide you with our promised response to the "Medical Device: Managing the Mismatch" report which was issued at the First… Continue reading »
This position paper of the Global Medical Technology Alliance (GMTA) is an internal statement of principles intended to offer participating associations a guideline for consistent non-binding, voluntary application at a national or regional level. As circumstances differ in each market, national associations should choose whether to use the GMTA principles as an appropriate reflection of… Continue reading »
This position paper of the Global Medical Technology Alliance is an internal statement of principles intended to offer participating associations a guideline for consistent nonbinding, voluntary application at a national or regional level. As circumstances differ in each market, national associations should choose whether to use the GMTA principles as an appropriate reflection of local… Continue reading »
The GMTA strongly supports WHO's mission to increase access to affordable diagnostics of assured quality in underserved regions of the world. We share WHO's concern for the quality and suitability of diagnostic products intended for use in those regions of the world, and we recognize the need for a product and quality system review of manufacturers not already subject to appropriate regulation. Continue reading »